海外の治験の状況「1」での検索結果
199件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- Formulation effect in patients with Alopecia Areata
- Alopecia areata; Alopecia in Areas L63 C17.800.329.937.122.147;L00-L99;C17.800.329.937.122.147
- Brazil
- 2017-12-14
Recruiting
- International Collaborative Gaucher Group (ICGG) Gaucher Registry
- Cerebroside Lipidosis Syndrome;Glucocerebrosidase Deficiency Disease;Glucosylceramide Beta-Glucosidase Deficiency Disease;Gaucher Disease
- Australia, Brazil, Canada, China, Egypt, France, Hong Kong, Italy, Japan, Korea, Republic of, Malaysia, Peru, Philippines, Singapore, Slovakia, South Africa, Sweden, Thailand, United States
- 2006-07-12
Recruiting
- Survival analysis of glass ionomer cement restorations after carious tissue removal using or not Brix3000: randomized controlled clinical trial
- Dental caries, Papain, dental materials, pediatric dentistry Dental Caries Papain Dental Materials Pediatric Dentistry;Dental Caries;Papain;Dental Materials;Pediatric Dentistry
- Brazil
- 2020-01-29
Recruiting
- Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)
- Myelodysplastic Syndrome;Leukemia, Myelomonocytic, Chronic;Leukemia, Myeloid, Acute
- Australia, Belgium, Brazil, Canada, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Turkey, United Kingdom, United States
- 2017-08-30
Recruiting
- A PHASE IIIB, RANDOMIZED, OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF DOLUTEGRAVIR OR EFAVIRENZ EACH ADMINISTERED WITH TWO NRTIS IN HIV-1-INFECTED ANTIRETROVIRAL THERAPY-NAÏVE ADULTS STARTING TREATMENT FOR RIFAMPICIN-SENSITIVE TUBERCULOSIS
- -B200 HIV disease resulting in mycobacterial infection HIV disease resulting in mycobacterial infection;HIV disease resulting in mycobacterial infection
- Argentina, Brazil, Mexico, Peru, Russian Federation, South Africa, Thailand
- 2015-04-30
Recruiting
- A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
- Cushing's Disease, # Acromegaly;E24 - Cushing syndrome;E22.0 - Acromegaly and pituitary gigantism
- Belgium, Brazil, China, Denmark, Germany, India, Peru, Poland, Russian Federation, Thailand, Turkey, United States
- 2015-02-26
Recruiting
- Genetic Association Study Between GAD1 and Reelin Polymorphisms and GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy Controls: SPECGENE PROJECT
- Bipolar Disorder
- Brazil
- 2010-11-08
Recruiting
- Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A
- Severe Haemophilia A
- Australia, Austria, Belgium, Brazil, Canada, Chile, China, France, Germany, Hong Kong, India, Italy, Japan, New Zealand, Poland, Russian Federation, South Africa, Spain, Sweden, Switzerland, United Kingdom, United States of America
- 2011-11-02
Recruiting
- A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures
- Epilepsy, Partial Seizures;Epilepsy, Primary Generalized Tonic-Clonic Seizures
- Argentina, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, China, Croatia, Czech Republic, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, India, Israel, Italy, Korea, Republic of, Lebanon, Lithuania, Malaysia, Montenegro, Netherlands, Philippines, Poland, Romania, Russian Federation, Serbia, Singapore, Slovakia, South Africa, Spain, Taiwan, Thailand, Turkey, Ukraine, United Kingdom, United States
- 2011-10-17
Recruiting
- A Study without Drug Intervention to Observe Bleeding Episodes, Factor VIII Infusions, and Patient-Reported Outcomes in Individuals with Severe Hemophilia A
- Severe Hemophilia A C15.378.100.100.500;D50-D89;C15.378.100.100.500
- Brazil, France, Germany, Israel, Italy, Japan, South Africa, Spain, United Kingdom, United States
- 2018-11-06